- Home
- News & Events
- In the News
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
DCT Tracker: Charting the next chapter for decentralisation
More than four years after decentralisation became a necessity in the clinical trials space, the sector is still finding its way around decentralised clinical trials (DCTs). And like any other paradigm shift, the journey has taken several turns.
-
Liver disease, obesity and the value of treatment
This article by Dr Alan Baldridge and Jolanta M. Wichary, discusses the link between obesity and metabolic-dysfunction associated steatotic liver disease (MASLD), and touches on recent advancements in effective treatments for obesity.
-
ACRO Good Clinical Podcast: Paediatric clinical trials: Compassion in action
Jacqui Whiteway, Senior Director & Paediatric Strategy Liaison, Centre for Paediatric Clinical Development at ICON participates in this discussion on what makes paediatric clinical trials unique and how the industry can make participation easier for paediatric patients and their families.
-
Interview with Andy Coravos
In this article from INTELLIGENT health.tech, Andy Coravos, founder of HumanFirst, recently acquired by ICON, shares insights on leveraging digital health technologies and wearables to manage chronic conditions. Drawing from her recent Lancet Digital Health review, Coravos highlights the potential of smartwatches and fitness trackers in improving patient outcomes and easing the burden on healthcare systems.
-
Symphony Health RWD utilized to determine prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease
Real world data from Symphony Health, an ICON plc company, was used in this retrospective, observational study on prevalence of tendon rupture and tendinopathies among patients with atherosclerotic cardiovascular disease. These results may help healthcare providers to determine the underlying risk of tendon injuries and guide treatment of this patient population.
-
Engaging minority communities: collaborative practises and long-term success
Rare diseases can disproportionately affect minorities, yet these communities are often underrepresented in clinical studies. ICON’s experts suggest ways to improve engagement and diversity.
-
Human-enabled AI driving enhancements in clinical trial site selection
In this piece from Clinical Trial Vanguard, Travis Caudill, Vice President, Feasibility, Site Identification & Clinical Informatics explores the improvements in site selection that human-enabled AI is delivering.
-
Pharma’s obsession with obesity on rise
ICON experts, Jack Martin and Simon Bruce share insights with BioSpectrum Asia on emerging trends in obesity treatment and the future implications for pharma.
-
Building on biotech confidence with strategic R&D
In this article from BIO-IT World, Dr. Chris Smyth, President of ICON Biotech outlines how despite ongoing challenges, biotech companies can build on growing market confidence by utilising their capital in the most effective and efficient way possible, through improved trial designs, timelines and data-responsive strategies.
-
EMA consolidates guidelines for computerised systems in clinical trials
To guide sponsors, investigators, CROs, and other parties in clinical research, the European Medicines Agency (EMA) has consolidated the contemporary requirements for using computerized systems and electronic data in clinical trials.